news
Kēpos launches 300-person trial testing breast milk bioactives for adult digestion
Supplement brand Kēpos launched a 300-person randomized, placebo-controlled trial testing human milk oligosaccharides (HMOs) and recombinant human lactoferrin in adults with digestive distress. The study tracks whether ingredients standard in infant nutrition can calm adult bloating and improve gut barrier integrity. If the data holds, infant bioactives are set to challenge traditional probiotics in adult gut care.
Supplement brand Kēpos launched a 300-person randomized, placebo-controlled trial testing human milk oligosaccharides (HMOs) and recombinant human lactoferrin in adults with digestive distress. The study tracks whether ingredients standard in infant nutrition can calm adult bloating and improve gut barrier integrity. If the data holds, infant bioactives are set to challenge traditional probiotics in adult gut care.
The architecture take
I never bought into colostrum. I used to roll my eyes whenever friends suggested adults take infant milk ingredients. Then I watched half my group chat spend $60 a month on powders that mostly taste like chalky dairy. Kēpos is skipping the cow and running a 300-person placebo-controlled trial on human milk oligosaccharides and biofermented lactoferrin in adults with chronic gut distress. HMOs act as precise food for beneficial Bifidobacteria while starving out the bugs that produce gas. Lactoferrin binds free iron in the lumen, starving opportunistic bacteria before they trigger gut barrier inflammation. I changed my mind about the approach once precision fermentation made bio-identical human bioactives accessible. If this trial confirms real symptom drops, legacy probiotic brands will scramble to license these molecules before winter.